23 May 2013
Keywords: pharmacopeia, cxcr2, drug, shows, efficacy, ph, innovator
Article | 20 March 2006
Pharmacopeia, a US innovator in the discovery and development of novel small-molecule therapeutics, says that a CXCR2 antagonist, developed in
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 March 2006
22 May 2013
© 2013 thepharmaletter.com